Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AVATION PLC Regulatory Filings 2021

Oct 28, 2021

4886_tar_2021-10-28_dd086baa-ef8c-45de-92b8-10215677ea12.html

Regulatory Filings

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 5679Q

Avast PLC

28 October 2021

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

FOR IMMEDIATE RELEASE

28 October 2021

RECOMMENDED MERGER

of

AVAST PLC

with

NORTONLIFELOCK INC.

CORRECTION:  Publication of Scheme Document by Avast plc

A prior announcement today incorrectly stated that a scheme document had been published and posted to its shareholders by Avast plc and that a prospectus had been published by NortonLifelock Inc. This announcement was released in error, and these documents have not yet been published, posted or otherwise made available.  Further details will be provided in due course.

Contacts

Avast
Peter Russell, Director of Investor Relations [email protected]
Stephanie Kane, VP PR and Corporate Communications
UBS (Financial adviser and Corporate Broker to Avast) Tel: +44 207 567 8000
Christian Lesueur
Rahul Luthra
Jonathan Rowley
Aadhar Patel
Meera Sheth
J.P. Morgan Cazenove (Financial adviser and Corporate Broker to Avast) Tel: +44 207 742 4000
Bill Hutchings
James Robinson
James Summer
Jonty Edwards
Finsbury Glover Hering (Communications adviser to Avast) [email protected]
Dorothy Burwell Tel: +44 7733 294 930
Nidaa Lone Tel: +44 7841 400 607

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCUWSBRANURURA